
Indo US Bio-Tech Ltd is Rated Sell
2026-11-19 10:10:57Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 Nov 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 November 2026, providing investors with the most up-to-date insight into the stock’s performance and outlook.
Read MoreIndo US Bio-Tech Ltd Gains 16.06%: 3 Key Factors Driving the Week’s Volatility
2026-10-31 13:02:08Key Events This Week Oct 26: New 52-week low at Rs.60.02 amid continued downtrend Oct 27: Surged to upper circuit with 19.99% gain closing at Rs.72.02 Oct 28: Hit upper circuit again, rising 19.99% to Rs.86.42 Oct 29-30: Profit booking led to declines, closing week at Rs.73.70 (-5.25% on 30 Oct) Week OpenRs.63.50 Week Close...
Read More
Indo US Bio-Tech Ltd is Rated Sell
2026-10-29 10:10:55Indo US Bio-Tech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 October 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read More
Indo US Bio-Tech Ltd Locks at Upper Circuit With 17.13% Gain — Buyers Queue, Sellers Absent
2026-10-28 10:00:32At Rs 84.77, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Indo US Bio-Tech Ltd locked at its upper circuit of 20% on 27 Oct 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Indo US Bio-Tech Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent
2026-10-27 10:00:39At Rs 72.37, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Indo US Bio-Tech Ltd locked at its upper circuit of 20% on 27 Oct 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Indo US Bio-Tech Ltd is Rated Sell
2026-10-18 10:10:17Indo US Bio-Tech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 October 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
31-Oct-2026 | Source : BSENewspaper Publication Unaudited Financial Results for the quarter ended on 30-09-2026.
Results- Financial Results For September 30 2026
30-Oct-2026 | Source : BSEUnaudited Financial Results for the quarter ended on 30-09-2026
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday October 30 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
30-Oct-2026 | Source : BSEPursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation 2015 we wish to inform you that the Board of Directors of the Company at their meeting held on Friday October 30 2026 at the registered office of the Company situated at 309 Shanti Mall Satadhar Char Rasta Opp. Navrang Tower Sola Road Ahmedabad Gujarat 380061 have considered and approved the following items of business:
Corporate Actions
No Upcoming Board Meetings
Indo US Bio-Tech Ltd has declared 2% dividend, ex-date: 03 Dec 24
No Splits history available
Indo US Bio-Tech Ltd has announced 1:1 bonus issue, ex-date: 29 Aug 23
No Rights history available


